During the past decade, Asthma & Allergy of Idaho conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Asthma & Allergy of Idaho" are "Asthma" (3 trials), "Chronic Rhinosinusitis" (2 trials) and "Nasal Polyps" (2 trials). Many other conditions were trialed in "Asthma & Allergy of Idaho" in a lesser frequency.

Most popular intervention types in "Asthma & Allergy of Idaho" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Omalizumab" (3 trials), "Lebrikizumab" (1 trials) and "MSTT1041A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Asthma & Allergy of Idaho" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Asthma & Allergy of Idaho". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Asthma & Allergy of Idaho, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Asthma & Allergy of Idaho, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".